Outcomes of Patients With COVID-19 After Discharged With Supplemental Home Oxygen

Posted March 30, 2021 by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 1, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3990?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: This observational study examined death and hospital readmission rates of patients with COVID-19 pneumonia after being discharged to home or quarantine housing with supplemental home oxygen.

Authors: Brad Spellberg, M.D., of the Los Angeles County + University of Southern California Medical Center in Los Angeles, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.3990)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Changes in Article Views in Leading Medical Journals During COVID-19

Posted March 30, 2021 by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 1, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.6459?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers assessed changes in the number of views of articles published in three leading medical journals since the start of the COVID-19 pandemic.

Authors: Andrew J. Giustini, M.D., Ph.D., of the Stanford University School of Medicine in Stanford, California, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.6459)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Trends in Blood Pressure Among US Children, Teens

Posted March 30, 2021 by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 1, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3917?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=040121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Nationally representative data were used to look at whether systolic and diastolic blood pressure levels among children and adolescents in the United States have changed during the past 20 years.

Authors: Shakia T. Hardy, Ph.D., of the University of Alabama at Birmingham, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.3917)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association Between Renin-Angiotensin-Aldosterone System Inhibitors, Clinical Outcomes in Patients With COVID-19

Posted March 29, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 31, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3594?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=033121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers compared mortality and severe adverse events in this systematic review and meta-analysis of 52 studies that evaluated clinical outcomes among nearly 102,000 patients with COVID-19 who did and didn’t receive angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs).

Authors: Vassilios S. Vassiliou, M.B.B.S., Ph.D., of the University of East Anglia in Norwich, United Kingdom is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.3694)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Risk Factors Associated With SARS-CoV-2 Infections, Hospitalization,Mortality Among US Nursing Home Residents

Posted March 29, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 31, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.6315?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=033121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: This study identified risk factors for SARS-CoV-2 incidence, hospitalization and death among nursing home residents in the United States.

Authors: James S. Goodwin, M.D., of the University of Texas Medical Branch in Galveston, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.6315)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Risk Factors for Complications From COVID-19, Perceived Chances of Infection and Protective Behavior

Posted March 29, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 31, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3984?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=033121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: This study documented how perception of risk of infection and severe complications from COVID-19 were associated with underlying reported health.

Authors: Robert F. Schoeni, Ph..D., of the University of Michigan in Ann Arbor, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.3984)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Simulation-Based Estimation of SARS-CoV-2 Infections Associated With School Closures and Community-Based Interventions

Posted March 29, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 31, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3793?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=033121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: In this decision analytical modelling study, researchers investigated the association of school reopening or closure with new and cumulative COVID-19 case numbers compared with other community-based interventions.

Authors: David Naimark, M.D., M.Sc., of the Sunnybrook Health Sciences Centre in Toronto, Canada, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.3793)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Dermatologist Perceptions of Teledermatology Implementation, Future Use After COVID-19

Posted March 29, 2021 by Deanna Bellandi

JAMA Dermatology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 31, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2021.0195?guestAccessKey=d92ee468-3dce-4e95-b610-99d3868f0524&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033121

What The Study Did: This study sought to assess dermatologists’ perceptions of and experiences with teledermatology in the context of the COVID-19 pandemic and new regulatory changes including parity in reimbursements between video and in-person visits.

Authors: Jules B. Lipoff, M.D., of the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, is the corresponding author.

(doi:10.1001/jamadermatol.2021.0195)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Race/Ethnicity With Likelihood of COVID-19 Vaccine Uptake Among Health Workers, General Population

Posted March 29, 2021 by Deanna Bellandi

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 30, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.1445?guestAccessKey=90ef183f-4c90-4eec-8ba6-2d307add7533&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033021

What The Study Did: Researchers investigated COVID-19 vaccine intentions among racially and ethnically diverse samples of health workers and the general population in the San Francisco Bay area.

Authors: Kevin Grumbach, M.D., of the San Francisco General Hospital and University of California, San Francisco, is the corresponding author.

(doi:10.1001/jamainternmed.2021.1445)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.1445?guestAccessKey=90ef183f-4c90-4eec-8ba6-2d307add7533

Here’s a link to provide your readers free access to the full-text article

Posted March 29, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3227?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=033121

Here’s a link to provide your readers free access to the full-text article

Posted March 29, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2021.0247?guestAccessKey=9db089e3-624b-483f-b725-08a89f8a5d68&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033121

Here’s a link to provide your readers free access to the full-text article

Posted March 29, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2021.0023?guestAccessKey=3fa30273-07db-4cfa-9879-39c0528a5f34&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033121

Here’s a link to provide your readers free access to the full-text article

Posted March 29, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3789?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=03312

Here’s a link to provide your readers free access to the full-text article

Posted March 26, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2021.0606?guestAccessKey=28952d1a-e8d1-4da1-b2f5-f3f52be0b65f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033021

How COVID-19 Affects the Brain

Posted March 25, 2021 by Deanna Bellandi

JAMA Psychiatry

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 26, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2021.0500?guestAccessKey=21cc4ac2-fdeb-492d-92ac-fea328aa9f34&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032621

What The Study Did: This article discusses possible pathogenic mechanisms of brain dysfunction in patients with COVID-19.

Authors: Maura Boldrini, M.D., Ph.D., of the New York State Psychiatric Institute, Columbia University Irving Medical Center in New York, is the corresponding author.

(doi:10.1001/jamapsychiatry.2021.0500)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 25, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3520?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032921

Here’s a link to provide your readers free access to the full-text article

Posted March 25, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3304?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032921

Here’s a link to provide your readers free access to the full-text article

Posted March 25, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3526?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032921

Assessment of Simulated SARS-CoV-2 Infection, Mortality Risk Associated With Radiation Therapy Among Patients in 8 RCTs

Posted March 25, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 29, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3304?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032921

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: This comparative effectiveness study investigates how the COVID-19 pandemic is associated with the benefits and risks of standard radiation therapy in simulated patients.

Authors: Rifaquat Rahman, M.D., of the Dana-Farber/Brigham and Women’s Cancer Center in Boston, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.3304)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 25, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2021.0054?guestAccessKey=b485a18e-0e11-40b4-b644-2688dcbb4ec4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032921

Here’s a link to provide your readers free access to the full-text article

Posted March 25, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.6981?guestAccessKey=84ec6be8-7880-4e99-89e9-42f08c11dec7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032921

Here’s a link to provide your readers free access to the full-text article

Posted March 25, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.6973?guestAccessKey=201cb53a-cbfe-4c41-8edb-6a2adc532120&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032921

Here’s a link to provide your readers free access to the full-text article

Posted March 25, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2021.0399?guestAccessKey=7f09fe9f-538e-4c1e-8af4-d60b7a1f7549&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032921

Use of Telehealth by Surgical Specialties During COVID-19 Pandemic

Posted March 24, 2021 by Deanna Bellandi

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 26, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2021.0979?guestAccessKey=949c82a5-772c-4871-bea0-c5b97d550b9b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032621

What The Study Did: Insurance claims were used to assess patterns of telehealth use across surgical specialties before and during the COVID-19 pandemic.

Authors: Grace F.Chao, M.D., M.Sc., of the National Clinician Scholars Program at the University of Michigan and Veterans Affairs Ann Arbor in Michigan, is the corresponding author.

(doi:10.1001/jamasurg.2021.0979)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 24, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3256?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032621

Here’s a link to provide your readers free access to the full-text article

Posted March 24, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3474?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032621

Here’s a link to provide your readers free access to the full-text article

Posted March 23, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3238?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032521

Here’s a link to provide your readers free access to the full-text article

Posted March 23, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3134?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032521

Here’s a link to provide your readers free access to the full-text article

Posted March 23, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.2723?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032521

Here’s a link to provide your readers free access to the full-text article

Posted March 23, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1974?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032521

Remdesivir and Clinical Improvement in Hospitalized Patients With COVID-19

Posted March 22, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 24, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3071?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032421

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: This comparative effectiveness research study that included a high proportion of non-White individuals assesses whether remdesivir administered alone or with corticosteroids is associated with time to clinical improvement or time to death in patients hospitalized with confirmed COVID-19.

Authors: Brian T. Garibaldi, M.D,. M.E.H.P., of the Johns Hopkins University School of Medicine in Baltimore, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.3071)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 22, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2021.0372?guestAccessKey=ed75bd13-e5b4-46c6-acdb-22ee239625e1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032421

Here’s a link to provide your readers free access to the full-text article

Posted March 22, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.5394?guestAccessKey=893c7ae7-d1f1-46d6-a7c2-c6b9d3f030a7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032421

Here’s a link to provide your readers free access to the full-text article

Posted March 22, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1271?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032421

Risk of Suicide Attempt After Diagnosis of Dementia

Posted March 22, 2021 by Jim Michalski

JAMA Psychiatry

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 24, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2021.0150?guestAccessKey=ea02e3c0-a638-4fee-b37c-a2b08af76810&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032421

What The Study Did: Researchers evaluated the association between a recent diagnosis of mild cognitive impairment or dementia and the risk of attempting suicide among older adults.

Authors: Amy L Byers, Ph.D., M.P.H., of the University of California, San Francisco, is the corresponding author.

(doi:10.1001/jamapsychiatry.2021.0150)

Editor’s Note: The article includes conflict of interest and funding and support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Microaggressions Against Surgeons, Anesthesiologists

Posted March 22, 2021 by Jim Michalski

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 24, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2021.0265?guestAccessKey=b0f9c79c-075d-4d15-8458-59ea44b74a5d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032421

What The Study Did: This survey study investigated the frequency and nature of sexist and racial/ethnic microaggressions against female and racial/ethnic–minority surgeons and anesthesiologists and the association with physician burnout.

Authors: Neha T. Sudol, M.D., of the Southern California Permanente Medical Group in Irvine, is the corresponding author.

(doi:10.1001/jamasurg.2021.0265)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 22, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1964?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032421

Trends in Health Care Worker Intentions to Receive COVID-19 Vaccine, Reasons for Hesitancy

Posted March 19, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 23, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.5344?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032321

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Employees of a health care system were surveyed on the eve of vaccine distribution to encourage them to receive a COVID-19 vaccine, assess their intentions to do so and understand reasons for hesitancy.

Authors: Michelle N. Meyer, Ph.D., J.D., Center for Translational Bioethics and Health Care Policy at the Geisinger Health System in Danville, Pennsylvania, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.5344)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

In-Person, Telehealth Care, Costs Before, During COVID-19 Pandemic

Posted March 19, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 23, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.2618?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032321

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: This study of working-age people enrolled in private health plans from March 2019 through June 2020 documented patterns of care at the onset of COVID-19.

Authors: Jonathan P. Weiner, Dr.P.H., Johns Hopkins Bloomberg School of Public Health in Baltimore, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.2618)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Representation of Black Americans in Clinical Trials of Cardiovascular Drugs

Posted March 19, 2021 by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 23, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.2640?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032321

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers investigated representation of Black Americans in clinical trials of cardiovascular drugs approved by the U.S. Food and Drug Administration between 2006 and 2020.

Authors: Jiarui Li, M.D., of the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, China, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.2640)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Age With SARS-CoV-2 Antibody Response

Posted March 18, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 22, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.4302?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032221

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: This study examined whether the quantity and quality of antibodies against SARS-CoV-2 were different among children, adolescents and young adults.

Authors: Zhen Zhao, Ph.D., of Weill Cornell Medicine in New York, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.4302)

Editor’s Note: The article includes conflict of interest and funding support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 18, 2021 by Deanna Bellandi

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1757?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032221

Effect on Weight Loss of Continued Treatment With Semaglutide vs Placebo Among Overweight Adults

Posted March 18, 2021 by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 2 P.M. (ET), TUESDAY, MARCH 23, 2021

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3224?guestAccessKey=31dd0155-9cd0-4a71-a7ee-79d16b82106a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032321

Visual Abstract

Authors: Domenica Rubino, M.D., of the Washington Center for Weight Management in Arlington, Virginia, is the corresponding author.

(doi:10.1001/jama.2021.3224)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 18, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0026?guestAccessKey=8796e01a-ec67-4d51-9692-cba9285ff1a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032321

Here’s a link to provide your readers free access to the full-text article

Posted March 18, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.0031?guestAccessKey=efdaa60e-adde-4faf-ac15-c1caab065b64&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032321

Budget Impact of Gene Therapy for Sickle Cell Disease

Posted March 18, 2021 by Jim Michalski

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 22, 2021

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.7140?guestAccessKey=eafaf224-0b11-42c0-888e-8b3555ec83fd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032221

What The Study Did: This economic evaluation estimates the budget impact and affordability of a gene therapy for severe sickle cell disease from the perspective of U.S. Medicaid programs with the highest prevalence of sickle cell disease.

Authors: Patrick DeMartino, M.D., of Oregon Health & Science University in Portland, is the corresponding author.

(doi:10.1001/jamapediatrics.2020.7140)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Incidental Findings in Brain MRIs of Children

Posted March 18, 2021 by Jim Michalski

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 22, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2021.0306?guestAccessKey=44a7e8e3-9b40-43e0-8739-2a2ae197fb1e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032221

What The Study Did: Rates and significance of incidental findings in brain magnetic resonance imaging (MRI) in children were investigated in this study.

Authors: Leo Sugrue, M.D., Ph.D., of the University of California, San Francisco, is the corresponding author.

(doi:10.1001/jamaneurol.2021.0306)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Hypertensive Disorders of Pregnancy, Neurodevelopmental Outcomes Among Offspring

Posted March 18, 2021 by Jim Michalski

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 22, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.6856?guestAccessKey=d05d4ce4-5142-468b-8115-3ccc781a2c2a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032221

What The Study Did: Researchers investigated associations of maternal hypertensive disorders of pregnancy and the risk of autism spectrum disorders, attention-deficit/hyperactivity disorder and intellectual disability in children as well as overall cognitive performance.

Authors: Judith S. Brand, Ph.D., of Örebro University in Örebro, Sweden, is the corresponding author.

(doi:10.1001/jamapediatrics.2020.6856)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Weight Changes During Pandemic-Related Shelter-in-Place

Posted March 18, 2021 by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 22, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.2536?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=032221

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers investigated whether shelter-in-place orders in the United States during the early weeks of the COVID-19 pandemic were associated with changes in body weight among adults.

Authors: Gregory M. Marcus, M.D., M.A.S., of the University of California, San Francisco, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.2536)

Editor’s Note: Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Unmet Need for Equipment to Help With Bathing, Toileting Among Older Adults

Posted March 18, 2021 by Jim Michalski

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 22, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.0204?guestAccessKey=771743a8-29d1-460f-ad44-1e76559c2ca6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032221

What The Study Did: This study estimates how many older adults in the United States who need equipment to help with bathing and toileting don’t have it and the factors associated with not having such equipment.

Authors: Kenneth Lam, M.D., University of California, San Francisco, is the corresponding author.

(doi:10.1001/jamainternmed.2021.0204)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

USPSTF Statement on Screening for Hearing Loss in Older Adults

Posted March 18, 2021 by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 23, 2021

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.2566?guestAccessKey=69d30dfe-cb23-4ea5-8037-b5669fef2d66&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032321

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) concludes that current evidence is insufficient to make a recommendation about screening for hearing loss in asymptomatic adults 50 and older. Nearly 16% of U.S. adults 18 and over report difficulty hearing. Hearing loss has been associated with an increased risk of falls, hospitalizations, social isolation and cognitive decline. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this recommendation is similar to its 2012 statement.

(doi:10.1001/jama.2021.2566)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Association of Vitamin D Levels, Race/Ethnicity, Clinical Characteristics With COVID-19 Test Results

Posted March 17, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 19, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.4117?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031921

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers examined if differences in vitamin D levels greater than levels traditionally considered sufficient (30 ng/mL) are associated with having test results positive for COVID-19 in White and in Black individuals.

Authors: David O. Meltzer, M.D., Ph.D., of the University of Chicago, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.4117)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Outcomes, Risk Factors Associated With SARS-CoV-2 Infection in North American Registry of Patients With MS

Posted March 17, 2021 by Deanna Bellandi

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 19, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2021.0688?guestAccessKey=d0f66c8e-e9ff-4588-95db-c24b75b0e93e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031921

What The Study Did: This analysis examined how patients with multiple sclerosis who have COVID-19 fare and what patient and disease characteristics are associated with worse outcomes.

Authors: Amber Salter, Ph.D., of Washington University in St Louis, is the corresponding author.

(doi:10.1001/jamaneurol.2021.0688)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Effectiveness of Acupuncture for Chronic Pain Among Cancer Survivors

Posted March 16, 2021 by Jim Michalski

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 18, 2021

Media advisory: The full article is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0310?guestAccessKey=a539fc06-0f39-4fd9-9bde-a74643c025d1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031821

Visual Abstract

Authors: Jun J. Mao, M.D., M.S.C.E., of the Memorial Sloan Kettering Cancer Center in New York, is the corresponding author.

(doi:10.1001/jamaoncol.2021.0310)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Counseling Patients in COVID-19 Era

Posted March 16, 2021 by Deanna Bellandi

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 18, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0125?guestAccessKey=8bb2301f-87a5-4ef2-a8b9-b4854a0509ca&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031821

What The Article Says: An oncologist reflects on how advising patients with cancer about travel during a pandemic requires a nuanced consideration of benefit and risk, especially when considering lost opportunities when prognosis is limited.

Authors: Christopher E. Jensen, M.D., of the University of North Carolina School of Medicine in Chapel Hill, is the corresponding author.

(doi:10.1001/jamaoncol.2021.0125)

Editor’s Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Evaluating State Marijuana Laws, Rates of Self-Harm, Assault

Posted March 16, 2021 by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 18, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1955?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031821

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers examined whether state medical and recreational cannabis laws were associated with changes in rates of self-harm and assault injuries.

Authors: Keith Humphreys, Ph.D., of Stanford University in Stanford, California, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1955)

Editor’s Note: Editor’s Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 15, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.5651?guestAccessKey=61f4a702-2655-40f7-a581-eef3787c82b2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031721

Here’s a link to provide your readers free access to the full-text article

Posted March 15, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2021.0137?guestAccessKey=d72aa92a-e388-4d76-982f-3615e2bbff64&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031721

Racial/Ethnic Disparities in Very Preterm, Preterm Birth Before, During COVID-19 Pandemic

Posted March 15, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 17, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1816?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031721

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Racial and ethnic disparities in very preterm birth and preterm birth among 8,026 women were similar during the first wave of the COVID-19 pandemic in New York City compared with the same period the year prior in this observational study.

Authors: Teresa Janevic, Ph.D., M.P.H., of the Icahn School of Medicine at Mount Sinai in New York, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1816)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Anesthesiologist Volume, Outcomes After Cancer Surgery

Posted March 15, 2021 by Jim Michalski

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 17, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2021.0135?guestAccessKey=e4d17118-52dd-4133-bbac-16c61a6592a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031721

What The Study Did: This observational study investigated the association between the annual number of complex gastrointestinal cancer surgeries supported by an anesthesiologist and short-term postoperative outcomes.

Authors: Julie Hallet, M.D., M.Sc., of the University of Toronto, is the corresponding author.

(doi:10.1001/jamasurg.2021.0135)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of PTSD, Ischemic Heart Disease in Women Veterans

Posted March 15, 2021 by Jim Michalski

JAMA Cardiology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 17, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2021.0227?guestAccessKey=62005265-3aab-45c7-8712-d15d80b7a37e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031721

What The Study Did: Researchers investigated whether posttraumatic stress disorder (PTSD) was associated with an increased risk of ischemic heart disease among women veterans.

Authors: Ramin Ebrahimi, M.D., of the Veterans Affairs Greater Los Angeles Health Care System in Los Angeles, is the corresponding author.

(doi:10.1001/jamacardio.2021.0227)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Nursing Home Characteristics Associated With Resident COVID-19 Morbidity in Communities With High Infection Rates

Posted March 12, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 16, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1555?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers examined nursing homes in communities with the highest COVID-19 prevalence to identify characteristics associated with resident infection rates.

Authors: Hye-Young Jung, Ph.D., of Weill Cornell Medical College in New York, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1555)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Seroprevalence of SARS-CoV-2 Antibodies in US Adult Asymptomatic Population

Posted March 12, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 16, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1552?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: The findings of this study suggest that, based on a sample from an otherwise healthy population, the overall number of SARS-CoV-2 infections in the U.S. may be substantially higher than estimates based on public health case reporting.

Authors: Robert L. Stout, Ph.D., of Clinical Reference Laboratory Inc. in Lenexa, Kansas, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1552)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 12, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1801?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031621

Here’s a link to provide your readers free access to the full-text article

Posted March 11, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.25879?guestAccessKey=4fe861d8-1b7d-4165-9de2-08617b7b8f12&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031621

Association of Preterm Birth Rate With COVID-19 Statewide Stay-at-Home Orders in Tennessee

Posted March 11, 2021 by Deanna Bellandi

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 15, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.6512?guestAccessKey=f2691229-5349-4172-ad48-b59efefbd614&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031521

What The Study Did: Researchers used Tennessee birth records from 2015 to 2020 to examine the odds of preterm birth in the state during the 2020 COVID-19 stay-at-home order compared with the same periods in 2015 to 2019.

Authors: Elizabeth M. Harvey, Ph.D., M.P.H., of the Tennessee Department of Health in Nashville, is the corresponding author.

(doi:10.1001/jamapediatrics.2020.6512)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Clinical, Biological, Brain MRI Findings With Electroencephalographic Findings for Patients With COVID-19

Posted March 11, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 15, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1489?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031521

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers analyzed neurologic manifestations, biological and electroencephalography (EEG, which records the brain’s electrical activity) findings plus brain MRI images in a study of 78 adult patients with COVID-19 in France.

Authors: Virginie Lambrecq, M.D., Ph.D., of the Sorbonne Université in Paris, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1489)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Psychotropic Drug Prescribing Among Nursing Home Residents in Canada During COVID-19 Pandemic

Posted March 11, 2021 by Deanna Bellandi

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 15, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.0224?guestAccessKey=0f885f87-584a-4d9f-991b-e8bd17a7ad1e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031521

What The Study Did: This population-based study of all nursing home residents in Ontario, Canada, found increased prescribing of psychotropic drugs at the onset of the COVID-19 pandemic that persisted through September 2020. Although absolute increases in prescribing were small, they were disproportionate to expected secular prescribing trends from April 2018 to February 2020, and they were distinct from observed prescribing changes for other drugs during the pandemic.

Authors: Nathan M. Stall, M.D., of Sinai Health and the University Health Network in Toronto, is the corresponding author.

(doi:10.1001/jamainternmed.2021.0224)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Screening Mammography Recommendations by Breast Cancer Centers

Posted March 11, 2021 by Jim Michalski

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 15, 2021

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.0157?guestAccessKey=6e8e37d9-2315-44c5-ad35-f6e8bfe347ae&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031521

What The Study Did: Researchers examined the screening mammography recommendations regarding starting age and interval for nearly 500 breast cancer centers in the United States.

Authors: Jennifer L. Marti, M.D., of Weill Cornell Medicine in New York, is the corresponding author.

(doi:10.1001/jamainternmed.2021.0157)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Investigating Effect of Marine Omega-3 Fatty Acid, Vitamin D Supplementation on Atrial Fibrillation

Posted March 11, 2021 by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 16, 2021

Media advisory: The full study and editor’s note are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1489?guestAccessKey=b8e23d8f-951c-44e5-a207-2032daac30bd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031621

Visual Abstract

Authors: Christine M. Albert, M.D., M.P.H., of the Cedars-Sinai Medical Center in Los Angeles, is the corresponding author.

(doi:10.1001/jama.2021.1489)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Acute Symptoms of COVID-19, Symptoms of Depression in Adults

Posted March 10, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 12, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.3223?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031221

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers investigated whether acute COVID-19 symptoms are associated with the probability of subsequent depressive symptoms.

Authors: Roy H. Perlis, M.D., M.Sc., of the Massachusetts General Hospital in Boston, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.3223)

Editor’s Note: Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Immunogenicity of Ad26.COV2.S Vaccine for COVID-19

Posted March 10, 2021 by Deanna Bellandi

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 11, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3645?guestAccessKey=1d3b0702-ad7c-4150-85fc-c526b5290ac0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031121

What The Study Did: In this phase 1 study, a single immunization with Ad26.COV2.S (Janssen/Johnson & Johnson) vaccine induced rapid binding and neutralization antibody responses as well as cellular immune responses. Two phase 3 clinical trials are currently underway to determine the efficacy of the Ad26.COV2.S vaccine.

Authors: Dan H. Barouch, M.D., Ph.D., of Beth Israel Deaconess Medical Center in Boston, is the corresponding author.

(doi:10.1001/jama.2021.3645)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 10, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1254?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031221

Association Between Preterm Birth, Psychotropic Drug Use in Adolescence, Young Adulthood

Posted March 10, 2021 by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 12, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1420?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031221

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers compared rates of psychotropic drug prescriptions during adolescence and young adulthood between individuals born preterm and at term.

Authors: Christine S. Bachmann, M.D., of the Norwegian University of Science and Technology in Trondheim, Norway, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1420)

Editor’s Note: Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

CDC Interim Recommendations for Fully Vaccinated People

Posted March 9, 2021 by Deanna Bellandi

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 10, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.4367?guestAccessKey=99033e7b-c0dd-4d45-b647-17b0cfa322c7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031021

What The Article Says: The Centers for Disease Control and Prevention has released its initial public health recommendations for fully vaccinated people (those at least two weeks out from having received their second Pfizer-BioNTech or Moderna vaccine dose or from their Janssen single-dose vaccine). These recommendations represent the first step for individuals in resuming their prepandemic lives.

Authors: Athalia Christie, M.I.A., of the CDC in Atlanta, is the corresponding author.

(doi:10.1001/jama.2021.4367)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Well-Child Visits With Out-of-Pocket Costs Before, After ACA

Posted March 10, 2021 by Jim Michalski

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 12, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1248?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031221

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: National claims data were used to look at changes in well-child care visits with out-of-pocket costs before and after passage of the Affordable Care Act.

Authors: Paul R. Shafer, Ph.D., of Boston University, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1248)

Editor’s Note: Editor’s Note: The article includes conflicts of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Experiences of Latinx Individuals Hospitalized for COVID-19

Posted March 9, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 11, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.0684?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Experiences of Latinx patients who were hospitalized with and survived COVID-19 are described in this study.

Authors: Lilia Cervantes, M.D., of Denver Health in Colorado, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.0684)

Editor’s Note: The article includes funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Cancer Surgery in Canadian Universal Health Care System During COVID-19

Posted March 9, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 11, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1104?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers sought to quantify cancer surgical backlog and determine whether there were differences in sociodemographic and hospital characteristics among patients undergoing cancer surgery before and during the COVID-19 pandemic.

Authors: Antoine Eskander, M.D., Sc.M., of Sunnybrook Health Sciences Centre in Toronto, Canada, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1104)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Assessment of Use, Fit of Face Masks Among People in Public During COVID-19 Pandemic in China

Posted March 9, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 11, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.2574?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031121

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: In this study of face mask fit among people in China, although most people used face masks in public places, compromised protection due to suboptimal airtightness was common. The simple approach of sealing the upper edge of the face mask with an adhesive tape strip was associated with substantially improved its airtightness.

Authors: Lin Duo, Ph.D., of Fuwai Yunnan Cardiovascular Hospital in Kunming, China, and Chengye Sun, Ph.D., of the National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention in Beijing, are the corresponding authors.

(doi:10.1001/jamanetworkopen.2021.2574)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Patient Perceptions of SARS-CoV-2 Exposure Risk, Association With Continuity of Ophthalmic Care

Posted March 9, 2021 by Deanna Bellandi

JAMA Ophthalmology

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 11, 2021

Media advisory: The full article and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2021.0114?guestAccessKey=6c07734f-7e6e-4c1c-a2ef-343d93e2d6be&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031121

What The Study Did: This nonvalidated telephone survey suggests that fear of COVID-19 exposure is associated with patients missing ophthalmic care appointments, suggesting the potential importance of clearly conveying infection-control measures.

Authors: Nieraj Jain, M.D., of the Emory University School of Medicine in Atlanta, andRajesh C. Rao, M.D., of the W.K. Kellogg Eye Center at the University of Michigan in Ann Arbor, is the corresponding author.

(doi:10.1001/jamaophthalmol.2021.0114)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Clear vs Covered Masks During Surgical Clinic Visits

Posted March 9, 2021 by Jim Michalski

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 11, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2021.0848?guestAccessKey=bbf17307-b2bf-4881-9209-87936b2df2a1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031121

What The Study Did: This randomized clinical trial evaluated the effect on patient perceptions of communication, trust and empathy of surgeons who wore clear masks that showed their faces versus standard masks that obscured them during outpatient clinic visits.

Authors: Muneera R. Kapadia, M.D., M.M.E., of the University of North Carolina at Chapel Hill, is the corresponding author.

(doi:10.1001/jamasurg.2021.0836)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel

Posted March 8, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 10, 2021

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1283?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031021

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: In this study, most risk factors associated with SARS-CoV-2 infection among health care workers were outside the workplace.

Authors: Jesse T. Jacob, M.D., of Emory University in Atlanta, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1283)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

SARS-CoV-2 Seroprevalence, Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple US Regions

Posted March 8, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 10, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.2816?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031021

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: This study of orthodox Jewisha dults across the United States found that socioculturally bound communities experienced early parallel outbreaks in discrete locations, notably prior to substantive medical and governmental directives.

Authors: Jonathan I. Silverberg, M.D., Ph.D., M.P.H., of George Washington University in Washington, D.C., and Avi Z. Rosenberg, M.D., Ph.D., of Johns Hopkins University in Baltimore, are the corresponding authors.

(doi:10.1001/jamanetworkopen.2021.2816)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Age With Likelihood of Developing Symptoms, Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection

Posted March 8, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 10, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1085?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031021

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: In a study of Italian close contacts of patients with confirmed SARS-CoV-2 infection, most infected contacts (1,948 of 2,824 individuals or 69%) didn’t develop respiratory symptoms or fever 37.5 degrees Celsius (99.5 degrees Fahrenheit) or higher; 26.1% of infected individuals younger than 60 developed respiratory symptoms or fever 37.5 degrees Celsius (99.5 degrees Fahrenheit); and 6.6% of infected participants age 60 or older developed critical disease.

Authors: Piero Poletti, Ph.D., of Fondazione Bruno Kessler in Trento, Italy, and Marcello Tirani, M.D., Directorate General for Health, Lombardy Region, in Milan, Italy, are the corresponding authors.

(doi:10.1001/jamanetworkopen.2021.1085)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Implementation of Recuperation Unit, Hospitalization Rates Among People Experiencing Homelessness With COVID-19

Posted March 8, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 10, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.2826?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031021

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Boston experienced a COVID-19 surge that disproportionately affected persons experiencing homelessness and a large safety-net hospital implemented a novel COVID-19 recuperation unit for these patients that provided isolation, quarantine and treatment for substance use. Researchers aimed to determine the association of the care provided by the unit with COVID-19 hospitalizations among people experiencing homelessness.

Authors: Joshua A. Barocas, M.D., of Boston Medical Center, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.2826)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Assessment of Acute Kidney Injury, Longitudinal Kidney Function After Hospital Discharge Among Patients With, Without COVID-19

Posted March 8, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 10, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1095?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031021

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Findings of this study suggest that patients recovering from COVID-19-associated acute kidney injury require monitoring of kidney function following hospital discharge.

Authors: F. Perry Wilson, M.D. M.S.C.E., of the Yale University School of Medicine in New Haven, Connecticut, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1095)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Characteristics, Mortality Associated With Diabetic Ketoacidosis Among US Patients Hospitalized With,Without COVID-19

Posted March 8, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 10, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.1091?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=031021

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers analyzed individual-level inpatient data from multiple U.S. hospital to further describe patients with diabetic ketoacidosis (a life-threatening complication of diabetes) with and without COVID-19.

Authors: Francisco J. Pasquel, M.D., M.P.H., of the Emory University School of Medicine in Atlanta, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.1091)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 9, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2021.0042?guestAccessKey=0792e5ef-39a1-45b0-84b7-92251a7d3da5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031021

Stigma Toward Those With Hair Loss

Posted March 8, 2021 by Jim Michalski

JAMA Dermatology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, MARCH 10, 2021

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2020.5732?guestAccessKey=bed1c70e-1f64-4dea-86d4-cabd2212e47f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031021

What The Study Did: Researchers in this survey study assessed the level of stigma toward people with varying degrees of hair loss

Authors: Arash Mostaghimi, M.D., M.P.A., M.P.H., of Brigham and Women’s Hospital in Boston, is the corresponding author.

(doi:10.1001/jamadermatol.2020.5732)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 5, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.0989?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=030921

Hospital Admissions Associated With Noncommunicable Diseases During COVID-19 Outbreak in Brazil

Posted March 4, 2021 by Deanna Bellandi

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 8, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.0799?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=030821

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

What The Study Did: Researchers assessed the number of hospital admissions for noncommunicable diseases (abnormal tissue growths, metabolic diseases, cardiovascular diseases and musculoskeletal diseases) in São Paulo, Brazil, between January and June last year compared with the corresponding periods in the previous three years.

Authors: Fernando Adami, Ph.D., of the Laboratório de Epidemiologia e Análise de Dados, Centro Universitário Saúde ABC in São Paulo, Brazil, is the corresponding author.

(doi:10.1001/jamanetworkopen.2021.0799)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Here’s a link to provide your readers free access to the full-text article

Posted March 4, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2021.0178?guestAccessKey=cd8338ce-af6a-4d56-af3b-99ec3773b390&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030821

Here’s a link to provide your readers free access to the full-text article

Posted March 4, 2021 by Jim Michalski

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2021.0036?guestAccessKey=40659c6e-b3b5-475f-b382-c75acadc7d0d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030821

Neurologic Involvement in Children, Adolescents Hospitalized in US for COVID-19 or Multisystem Inflammatory Syndrome

Posted March 4, 2021 by Deanna Bellandi

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MARCH 5, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2021.0504?guestAccessKey=02a71af9-7c46-4def-bbf6-bddeec45ab26&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030521

What The Study Did: In this study, many children and adolescents hospitalized for COVID-19 or multisystem inflammatory syndrome in children had neurologic involvement, mostly transient symptoms. A range of life-threatening and fatal neurologic conditions associated with COVID-19 infrequently occurred. Effects on long-term neurodevelopmental outcomes are unknown.

Authors: Adrienne G. Randolph, M.D., of Boston Children’s Hospital, is the corresponding author.

(doi:10.1001/jamaneurol.2021.0504)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Persistence of THC in Breast Milk

Posted March 4, 2021 by Jim Michalski

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MARCH 8, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.6098?guestAccessKey=c707bcf3-fceb-4cfb-8467-1d4552426fe9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030821

What The Study Did: This study estimated the amount and duration of excretion of THC (the main active ingredient in marijuana) in breast milk of women who had just delivered an infant and had used marijuana during pregnancy.

Authors: Erica M. Wymore, M.D., M.P.H., of the University of Colorado School of Medicine in Aurora, is the corresponding author.

(doi:10.1001/jamapediatrics.2020.6098)

Editor’s Note: The article includes conflict of interest and funding and support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Social Distancing Policies, Changes in Traffic Volume, Accidents, Injuries

Posted March 4, 2021 by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 9, 2021

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2020.25770?guestAccessKey=9fff0a01-d8e4-425b-99e0-0cd8e97d0d04&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030921

What The Study Did: Researchers compared traffic volume and motor vehicle crash injuries before, during and after COVID-19-related state-of-emergency and stay-at-home orders in Ohio from January to July last year with the same period in 2019.

Authors: Motao Zhu, Ph.D., of the Abigail Wexner Research Institute at Nationwide Children’s Hospital in Columbus, Ohio, is the corresponding author.

(doi:10.1001/jama.2020.25770)

Editor’s Note: The article includes conflicts of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

USPSTF Recommendation Statement on Screening for Lung Cancer Among Current, Former Smokers

Posted March 4, 2021 by Jim Michalski

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, MARCH 9, 2021

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.1117?guestAccessKey=8eaa560b-dad2-40c0-b7f4-e2979c6455f4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030921

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends annual screening for lung cancer with low-dose computed tomography in adults 50 to 80 years of age at high risk of lung cancer based on total cumulative exposure to tobacco smoke and whether they currently smoke or have quit within the past 15 years. Lung cancer is the second most common cancer and the leading cause of cancer death in the U.S. The most important risk factor is smoking. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this statement replaces the 2013 recommendation.

(doi:10.1001/jama.2021.1117)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19

Posted March 3, 2021 by Deanna Bellandi

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 4, 2021

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3071?guestAccessKey=e98010ef-e747-40ad-b865-a18c9c0450d9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030421

What The Study Did: This randomized clinical trials reports that among adults with mild COVID-19, a five-day course of ivermectin, compared with placebo, didn’t significantly improve the time to resolution of symptoms. The findings don’t support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes.

Authors: Eduardo López-Medina, M.D., M.Sc., of the Centro de Estudios en Infectología Pediátrica in Cali, Colombia, is the corresponding author.

Visual Abstract:

(doi:10.1001/jama.2021.3071)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

COVID-19 in 2021

Posted March 3, 2021 by Deanna Bellandi

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 4, 2021

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2021.3760?guestAccessKey=e48b8a88-d64d-4a6b-a5a0-f777b0538b07&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030421

What The Article Says: Current best evidence about COVID-19 vaccines, immunity and whether SARS-CoV-2 will become an endemic or seasonal virus is summarized in this Viewpoint.

Authors: Carlos del Rio, M.D., of the Emory University School of Medicine in Atlanta, is the corresponding author.

(doi:10.1001/jama.2021.3760)

Editor’s Note: The article includes conflict of interest disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.